Company / Operating Income per Share
GT Biopharma, Inc. Operating Income per Share History
FY2011-FY2020 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Operating Income per Share
$3.91
FY2020
5-year range
-$89.95 / $3.91
FY2016-FY2020
Trend
+104.3%
vs FY2019
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Operating Income per Share returned to growth in FY2020 after 3 years of decline, reaching $3.91.
Based on SEC 10-K filings.
3.91 in FY2020.
Improved from $-3.72 to $3.91 over the past 4 years.
Operating Income per Share over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2020, operating income per share increased 104.3% year-over-year.
- Lowest operating income per share in the period was in FY2017.
Company context
Key Data Points
- Low Piotroski F-Score: 1/9 (multiple financial health concerns)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Operating Income per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2020 | $3.91 | +104.3% |
| FY2017 | -$89.95 | -2318.2% |
| FY2016 | -$3.72 | -267.4% |
| FY2015 | -$1.01 | -73061.8% |
| FY2014 | -$0.00 | +80.3% |
| FY2013 | -$0.01 | +51.9% |
| FY2012 | -$0.01 | +12.6% |
| FY2011 | -$0.02 | - |
As of FY2020 · SEC 10-K · Updated Jun 24, 2026